Treatment Arm
Visit number vs Triglycerides
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 49 | 172.5 | ± 80.3 | 151.0 | 60.0 | 487.0 | - | 49 |
9-Month Followup | 43 | 161.6 | ± 91.6 | 126.0 | 54.0 | 530.0 | - | 43 |
18-Month Followup | 40 | 169.0 | ± 111.5 | 143.5 | 49.0 | 548.0 | - | 40 |
Randomized treatment arm vs Triglycerides
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 172.5 | ± 80.3 | 151.0 | 60.0 | 487.0 | - | 49 |
Laparoscopic Gastric Banding (LGB) | 28 | 163.0 | ± 73.0 | 149.0 | 60.0 | 371.0 | - | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 185.2 | ± 89.4 | 157.0 | 77.0 | 487.0 | - | 21 |
Randomized treatment arm vs Triglycerides
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 161.6 | ± 91.6 | 126.0 | 54.0 | 530.0 | - | 43 |
Laparoscopic Gastric Banding (LGB) | 25 | 153.1 | ± 78.7 | 126.0 | 54.0 | 302.0 | - | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 173.3 | ± 108.4 | 139.0 | 73.0 | 530.0 | - | 18 |
Randomized treatment arm vs Triglycerides
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 169.0 | ± 111.5 | 143.5 | 49.0 | 548.0 | - | 40 |
Laparoscopic Gastric Banding (LGB) | 24 | 163.1 | ± 121.6 | 131.0 | 54.0 | 548.0 | - | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 177.8 | ± 97.5 | 146.5 | 49.0 | 403.0 | - | 16 |
Age of the participant vs Triglycerides
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 172.5 | ± 80.3 | 151.0 | 60.0 | 487.0 | - | 49 |
27.0 to 45.0 years | 13 | 189.7 | ± 77.4 | 149.0 | 107.0 | 371.0 | - | 13 |
46.0 to 50.0 years | 12 | 154.8 | ± 67.1 | 153.5 | 64.0 | 246.0 | - | 12 |
51.0 to 56.0 years | 12 | 196.7 | ± 111.7 | 177.5 | 77.0 | 487.0 | - | 12 |
57.0 to 65.0 years | 12 | 147.4 | ± 51.0 | 141.5 | 60.0 | 229.0 | - | 12 |
Age of the participant vs Triglycerides
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 161.6 | ± 91.6 | 126.0 | 54.0 | 530.0 | - | 43 |
28.0 to 47.0 years | 11 | 200.0 | ± 138.0 | 123.0 | 72.0 | 530.0 | - | 11 |
47.0 to 52.0 years | 11 | 144.5 | ± 78.0 | 125.0 | 56.0 | 302.0 | - | 11 |
52.0 to 58.0 years | 11 | 159.9 | ± 62.7 | 172.0 | 64.0 | 245.0 | - | 11 |
58.0 to 65.0 years | 10 | 139.8 | ± 64.9 | 119.5 | 54.0 | 272.0 | - | 10 |
Age of the participant vs Triglycerides
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 169.0 | ± 111.5 | 143.5 | 49.0 | 548.0 | - | 40 |
29.0 to 46.0 years | 10 | 229.0 | ± 129.5 | 178.5 | 113.0 | 491.0 | - | 10 |
47.0 to 52.0 years | 10 | 145.0 | ± 146.2 | 102.0 | 49.0 | 548.0 | - | 10 |
53.0 to 58.0 years | 10 | 172.0 | ± 76.3 | 161.5 | 71.0 | 332.0 | - | 10 |
58.0 to 65.0 years | 10 | 129.9 | ± 59.5 | 125.0 | 54.0 | 209.0 | - | 10 |
Gender of the participant vs Triglycerides
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 172.5 | ± 80.3 | 151.0 | 60.0 | 487.0 | - | 49 |
Male | 28 | 189.6 | ± 92.1 | 169.0 | 64.0 | 487.0 | - | 28 |
Female | 21 | 149.7 | ± 55.5 | 144.0 | 60.0 | 246.0 | - | 21 |
Gender of the participant vs Triglycerides
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 161.6 | ± 91.6 | 126.0 | 54.0 | 530.0 | - | 43 |
Male | 25 | 182.6 | ± 105.8 | 172.0 | 56.0 | 530.0 | - | 25 |
Female | 18 | 132.3 | ± 58.0 | 120.0 | 54.0 | 247.0 | - | 18 |
Gender of the participant vs Triglycerides
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 169.0 | ± 111.5 | 143.5 | 49.0 | 548.0 | - | 40 |
Male | 25 | 194.1 | ± 130.0 | 160.0 | 49.0 | 548.0 | - | 25 |
Female | 15 | 127.1 | ± 51.7 | 117.0 | 54.0 | 246.0 | - | 15 |
Race of the participant vs Triglycerides
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 46 | 172.5 | ± 82.3 | 153.5 | 60.0 | 487.0 | - | 46 |
white | 35 | 177.7 | ± 88.6 | 157.0 | 60.0 | 487.0 | - | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 160.1 | ± 64.3 | 156.0 | 80.0 | 246.0 | - | 9 |
asian | 2 | 137.0 | ± 1.4 | 137.0 | 136.0 | 138.0 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Triglycerides
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 160.1 | ± 93.8 | 125.5 | 54.0 | 530.0 | - | 40 |
white | 31 | 157.6 | ± 98.9 | 124.0 | 54.0 | 530.0 | - | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 8 | 177.5 | ± 78.8 | 171.0 | 73.0 | 302.0 | - | 8 |
asian | 1 | 98.0 | - | 98.0 | 98.0 | 98.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Triglycerides
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 37 | 168.1 | ± 115.2 | 132.0 | 49.0 | 548.0 | - | 37 |
white | 29 | 167.7 | ± 102.6 | 141.0 | 54.0 | 491.0 | - | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 7 | 177.7 | ± 172.9 | 101.0 | 49.0 | 548.0 | - | 7 |
asian | 1 | 113.0 | - | 113.0 | 113.0 | 113.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |